A new research paper was published in Oncotarget's Volume 14 on June 19, 2023, entitled, "Utilizing metformin to prevent metabolic syndrome due to androgen deprivation therapy (ADT): a randomized phase II study of metformin in non-diabetic men initiating ADT for advanced prostate cancer."
Study investigates whether metformin mitigates androgen deprivation therapy-related metabolic syndrome
- Thread starter Educator
- Start date